HomeBody MapPeptidesCalculator
Catalog6 refs

Prostamax

BioregulatorsBioregulatoryResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Not Well Characterized
Half-life
26
Uses
20
Typical
Body Map
Loading 3D model…
chromatincells
Overview

Prostamax is a Khavinson bioregulator tetrapeptide (KEDP) with primary repair effects on prostate tissue. Developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology, it alters chromatin structure in cells from elderly individuals, promoting deheterochromatinization and potentially reactivating genes repressed during aging. Research in rat models shows reduced prostate inflammation, decreased swelling, and decelerated pathological remodeling associated with prostatitis.

Primary Uses
Prostate tissue health
Epithelial cell differentiation
Benign prostatic hyperplasia models
Prostatic aging research
Chronic aseptic prostatitis therapy
Reduces prostate inflammation
Decreases prostatic swelling
Reduces vascular congestion (hyperemia)
Decreases immune cell infiltration
Reduces scarring in prostate tissue
Promotes chromatin decondensation
Reactivates age-repressed genes
Improves lymphocyte function
Chronic prostatitis treatment
Prostatic inflammation mitigation
Prostate tissue repair
Chromatin remodeling
Gene reactivation
Lymphocyte function normalization
prostate research
prostate tissue support
modulate gene expression in prostate cells
influence protein synthesis in prostate
prostate inflammation
age-related prostate changes
prostate health
Protocol Reference
Dose
20–40 mg/day
Frequency
1–2 Times Daily With Food
Half-life
Not Well Characterized
Route
Oral
Evidence
Preclinical / Moderate Research / C (disputed)
Research References· 5
https://pubmed.ncbi.nlm.nih.gov/11713572/
PubMedPMID 11713572- [https://www.mdpi.com/1420-3049/26/22/7053](https://www.mdpi.com/1420-3049/26/22/7053)
Peptides (Epigenetic Regulators) in the Structure of Rodents with a Long and Short Lifespan.↗
PubMedPMID 28948547Bull Exp Biol Med2017Khavinson VK, Kormilets DY, Mar'yanovich AT
Experimental studying of the drug efficiency Prostamax in the therapy of chronic aseptic prostatitis and its complications↗
DOIModern Research in Inflammation2013Borovskaya T, Pakhomova A, Vychuzhanina A, et al.
Research Models
BovineHumanRatrodents
Also in Bioregulators
Bioregulators
Bonomarlot
Bone marrow support research · Hematopoiesis models
Bioregulators
Bonothyrk
Parathyroid function support · Calcium-phosphate homeostasis research
Bioregulators
Bronchogen
Airway inflammation models · Bronchial epithelial repair
Bioregulators
Cardiogen
Cardiac aging models · Myocardial repair signaling
Compare